X EUPHARLAW AWARD
JUAN JOSÉ RODRÍGUEZ SENDÍN. Born in Vitigudino, Salamanca in 1955 he holds a degree in Medicine from the University of Salamanca and a Bachelor’s Degree from the University of Valladolid.  He graduated in Health Studies from the National School of Public Health and in Industrial Health from the School of Industrial Medicine of Madrid.  In addition, he is specialised in Family and Community Medicine, has a Master’s Degree in Health Administration from the National School of Public Health.  His professional career includes positions such as Doctor at the Spanish Medical Association and since 1983 he has been part of the Primary Care team in Noblejas (Toledo).  Other mentions: Regional Board Member for the Medical Association in Toledo in 1985, founder of the Spanish Society of General Medicine (SEMG) in 1998 and its president from 1995-2001.  He was also a founding member of the foundation for international health cooperation SEMG Solidaria.  He was secretary general of the Spanish Medical Association (OMC) in June 2002 and since April 2009 has been its president.

X EUPHARLAW INTERNACIONAL AWARD
MARIANO BARBACID MONTALBÁN. Received a doctorate in Biochemistry from Madrid’s Complutense University in 1974. He is a member of various scientific advisory boards and editorial boards of scientific magazines.  The importance of his work has been recognised on many occasions; among them are the Distinguished Young Scientist Award (Maryland Academy of Sciences, 1983), the Rey Juan Carlos I Award (Spain, 1984), the Rhodes Memorial Award from the American Association on Cancer Research (USA, 1986), the Charles Rodolphe Brupbacher Cancer Prize, which he received together with Klaus Rajewsky in 2005, in Switzerland.  He also received the XXXIV Fundación Jiménez Díaz Prize in 2002.  Since 1984 he has been a research professor at the CSIC (Spanish National Research Council) (on extended leave of absence). He is a Doctor Honoris Causa at the Menendez Pelayo International University (1995) and has been an EMBO member since 1996.  In 1998 he set up the National Cancer Research Centre in Madrid and  is its director. He currently combines this position with research at the Experimental Cancer Group, of which he is head, and whose work focuses on the study of the role of regulators in in vivo cell cycles and the design of new models of animal cancer generated by genetic modification technology.